Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma

Abstract

The analysis of 824 DNAs from patients with PPGL demonstrated that NGS assay significantly improves the performances of PPGL genetic testing compared with conventional methods, increasing the rate of identified mutations and identifying rare genetic mechanisms.